{
  "guid": "71f30681-e145-44c1-820c-ad040008bd75",
  "title": "457. Is Dialysis a Test Case of Medicare for All?",
  "description": "<p>Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak the system if they wanted to make big profits. They succeeded.</p>\n",
  "pubDate": "Thu, 8 Apr 2021 03:00:00 +0000",
  "author": "editor@freakonomics.com (Freakonomics Radio + Stitcher)",
  "link": "http://freakonomics.com/",
  "content:encoded": "<p>Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak the system if they wanted to make big profits. They succeeded.</p>\n",
  "enclosure": "",
  "itunes:title": "457. Is Dialysis a Test Case of Medicare for All?",
  "itunes:author": "Freakonomics Radio + Stitcher",
  "itunes:image": "",
  "itunes:duration": "00:53:28",
  "itunes:summary": "Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak the system if they wanted to make big profits. They succeeded.",
  "itunes:subtitle": "Kidney failure is such a catastrophic (and expensive) disease that Medicare covers treatment for anyone, regardless of age. Since Medicare reimbursement rates are fairly low, the dialysis industry had to find a way to tweak the system if they wanted to make big profits. They succeeded.",
  "itunes:explicit": "no",
  "itunes:episodeType": "full"
}